BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33281395)

  • 21. The effects of co-administration of probiotics with herbal medicine on obesity, metabolic endotoxemia and dysbiosis: a randomized double-blind controlled clinical trial.
    Lee SJ; Bose S; Seo JG; Chung WS; Lim CY; Kim H
    Clin Nutr; 2014 Dec; 33(6):973-81. PubMed ID: 24411490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gut Microbiota Mediates the Protective Effects of Dietary Capsaicin against Chronic Low-Grade Inflammation and Associated Obesity Induced by High-Fat Diet.
    Kang C; Wang B; Kaliannan K; Wang X; Lang H; Hui S; Huang L; Zhang Y; Zhou M; Chen M; Mi M
    mBio; 2017 May; 8(3):. PubMed ID: 28536285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bletilla striata oligosaccharides improve metabolic syndrome through modulation of gut microbiota and intestinal metabolites in high fat diet-fed mice.
    Hu B; Ye C; Leung EL; Zhu L; Hu H; Zhang Z; Zheng J; Liu H
    Pharmacol Res; 2020 Sep; 159():104942. PubMed ID: 32504835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gut microbiota: a new path to treat obesity.
    Muscogiuri G; Cantone E; Cassarano S; Tuccinardi D; Barrea L; Savastano S; Colao A;
    Int J Obes Suppl; 2019 Apr; 9(1):10-19. PubMed ID: 31391921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical effect of Virechana and Shamana Chikitsa in Tamaka Shwasa (Bronchial Asthma).
    Ghosh KA; Tripathi PC
    Ayu; 2012 Apr; 33(2):238-42. PubMed ID: 23559796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An integrated therapy approach for the management of obesity-associated disorders: A case report.
    Verma A; Shete SU; Doddoli G
    J Family Med Prim Care; 2019 Apr; 8(4):1491-1494. PubMed ID: 31143747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gut microbiota-derived metabolites in obesity: a systematic review.
    Ejtahed HS; Angoorani P; Soroush AR; Hasani-Ranjbar S; Siadat SD; Larijani B
    Biosci Microbiota Food Health; 2020; 39(3):65-76. PubMed ID: 32775123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dysbiotic Gut Bacteria in Obesity: An Overview of the Metabolic Mechanisms and Therapeutic Perspectives of Next-Generation Probiotics.
    Breton J; Galmiche M; Déchelotte P
    Microorganisms; 2022 Feb; 10(2):. PubMed ID: 35208906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Gut microbiota and immune crosstalk in metabolic disease].
    Burcelin R
    Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An ayurvedic approach in the management of Siragatavata complicated with Dusta Vrana.
    Singh SK; Rajoria K; Sharma S
    J Ayurveda Integr Med; 2021; 12(1):151-155. PubMed ID: 32165016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Translational research into gut microbiota: new horizons on obesity treatment: updated 2014.
    Tsukumo DM; Carvalho BM; Carvalho Filho MA; Saad MJ
    Arch Endocrinol Metab; 2015 Apr; 59(2):154-60. PubMed ID: 25993679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gut microbiota and the development of obesity.
    Boroni Moreira AP; Fiche Salles Teixeira T; do C Gouveia Peluzio M; de Cássia Gonçalves Alfenas R
    Nutr Hosp; 2012; 27(5):1408-14. PubMed ID: 23478685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FOS/GOS attenuates high-fat diet induced bone loss via reversing microbiota dysbiosis, high intestinal permeability and systemic inflammation in mice.
    Zhang Z; Lin T; Meng Y; Hu M; Shu L; Jiang H; Gao R; Ma J; Wang C; Zhou X
    Metabolism; 2021 Jun; 119():154767. PubMed ID: 33753088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dysbiosis is one of the risk factor for stroke and cognitive impairment and potential target for treatment.
    Koszewicz M; Jaroch J; Brzecka A; Ejma M; Budrewicz S; Mikhaleva LM; Muresanu C; Schield P; Somasundaram SG; Kirkland CE; Avila-Rodriguez M; Aliev G
    Pharmacol Res; 2021 Feb; 164():105277. PubMed ID: 33166735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism.
    Amabebe E; Robert FO; Agbalalah T; Orubu ESF
    Br J Nutr; 2020 May; 123(10):1127-1137. PubMed ID: 32008579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
    Rizzetto L; Fava F; Tuohy KM; Selmi C
    J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rhubarb Enema Increasing Short-Chain Fatty Acids that Improves the Intestinal Barrier Disruption in CKD May Be Related to the Regulation of Gut Dysbiosis.
    Ji C; Lu F; Wu Y; Lu Z; Mo Y; Han L; Lin Q; Liu X; Zou C
    Biomed Res Int; 2022; 2022():1896781. PubMed ID: 35097110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Role and Mechanism of Intestinal Flora in Blood Pressure Regulation and Hypertension Development.
    Li J; Yang X; Zhou X; Cai J
    Antioxid Redox Signal; 2021 Apr; 34(10):811-830. PubMed ID: 32316741
    [No Abstract]   [Full Text] [Related]  

  • 39. Beneficial effects of exercise on gut microbiota functionality and barrier integrity, and gut-liver crosstalk in an
    Carbajo-Pescador S; Porras D; García-Mediavilla MV; Martínez-Flórez S; Juarez-Fernández M; Cuevas MJ; Mauriz JL; González-Gallego J; Nistal E; Sánchez-Campos S
    Dis Model Mech; 2019 Apr; 12(5):. PubMed ID: 30971408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of
    Pandya M; Donga SB; Dei LP; Thakar AB
    Ayu; 2020; 41(3):166-172. PubMed ID: 35370374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.